Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial (Q30497323)

19 October 2017

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial (English)

1 reference

19 October 2017

1 reference

John Burn

12

0 references

Ann Zauber

3

object named as

Ann G Zauber

1 reference

19 October 2017

1

Monica M Bertagnolli

1 reference

19 October 2017

17

Finlay Macrae

1 reference

19 October 2017

Craig J Eagle

2

1 reference

19 October 2017

Mark Redston

4

1 reference

19 October 2017

Aurora Breazna

5

1 reference

19 October 2017

Kyungmann Kim

6

1 reference

19 October 2017

Jie Tang

7

1 reference

19 October 2017

Rebecca B Rosenstein

8

1 reference

19 October 2017

Asad Umar

9

1 reference

19 October 2017

Donya Bagheri

10

1 reference

19 October 2017

Neal T Collins

11

1 reference

19 October 2017

Daniel C Chung

13

1 reference

19 October 2017

Thomas Dewar

14

1 reference

19 October 2017

T Raymond Foley

15

1 reference

19 October 2017

Neville Hoffman

16

1 reference

19 October 2017

Ronald E Pruitt

18

1 reference

19 October 2017

John R Saltzman

19

1 reference

19 October 2017

Bruce Salzberg

20

1 reference

19 October 2017

Thomas Sylwestrowicz

21

1 reference

19 October 2017

Ernest T Hawk

22

1 reference

19 October 2017

Adenoma Prevention with Celecoxib Study Investigators

23

1 reference

19 October 2017

31 March 2009

1 reference

Cancer Prevention Research

19 October 2017

1 reference

19 October 2017

2

1 reference

19 October 2017

4

1 reference

19 October 2017

310-321

1 reference

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Celecoxib for the prevention of sporadic colorectal adenomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

A randomized trial of aspirin to prevent colorectal adenomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Evaluation of survival data and two new rank order statistics arising in its consideration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Patterns and predictors of colorectal cancer test use in the adult U.S. population

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

Sulindac for polyposis of the colon.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976587

The evolution of cancer of the colon and rectum

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19336730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1940-6207.CAPR-08-0206

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

19336730

1 reference